102 related articles for article (PubMed ID: 11938765)
1. [Methodological study on the assay of glycosylphosphatidylinositol-specific phospholipase D activity in serum].
Tang J; Li W
Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):119-22. PubMed ID: 11938765
[TBL] [Abstract][Full Text] [Related]
2. [Effect of overexpression of glycosylphosphatidylinositol-specific phospholipase D on biological character of hepatocellular carcinoma cell line HepG2].
He WJ; Tang JH; Tan CC; Duan Q; Wang KJ; Zuo KQ; Yuan XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Feb; 33(2):103-9. PubMed ID: 18326903
[TBL] [Abstract][Full Text] [Related]
3. [GPI-PLD gene exon14 polymorphisms of leucocyte in peripheral blood from healthy persons and leukemia patients].
Yang ZY; Huang H; Tang JH; Yu H; Wang YD; Xiang XY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):28-31. PubMed ID: 16562670
[TBL] [Abstract][Full Text] [Related]
4. Important roles of glycosylphosphatidylinositol (GPI)-specific phospholipase D and some GPI-anchored proteins in the pathogenesis of hepatocellular carcinoma.
Tang JH; He WJ; Huang H; Tan CC; Duan Q; Wang KJ; Yuan XY; Zhu XJ
Clin Biochem; 2009 Mar; 42(4-5):400-7. PubMed ID: 19135435
[TBL] [Abstract][Full Text] [Related]
5. [Expression and activity of glycosylphosphatidylinositol-specific phospholipase d mRNA in bone marrow mononuclear cells isolated from patient with acute myeloid leukemia and their significance].
Xiao GF; Tang XY; Li X; Zeng C
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):15-8. PubMed ID: 20137110
[TBL] [Abstract][Full Text] [Related]
6. Statin therapy reduces serum levels of glycosylphosphatidylinositol-specific phospholipase D.
Deeg MA; Raikwar NS; Johnson C; Williams CD
Transl Res; 2007 Sep; 150(3):153-7. PubMed ID: 17761367
[TBL] [Abstract][Full Text] [Related]
7. Effect of glycosylphosphatidylinositol specific phospholipase D gene expression levels on complement mediated killing of leukemic cells in patients with chronic myeloid leukemia.
Jian-Hua T; Xiao-Jie Z; Yi-Dan W; Wen-Kai L; Wang-Jiao H; Cheng-Hong W; Gui-Yuan L
Clin Chim Acta; 2005 Sep; 359(1-2):115-24. PubMed ID: 15907827
[TBL] [Abstract][Full Text] [Related]
8. Midportion antibodies stimulate glycosylphosphatidylinositol-specific phospholipase D activity.
Deeg MA; Bowen RF
Arch Biochem Biophys; 1999 Oct; 370(2):278-84. PubMed ID: 10510287
[TBL] [Abstract][Full Text] [Related]
9. Immunolocalization of a glycosylphosphatidylinositol-specific phospholipase D in mast cells found in normal tissue and neurofibromatosis lesions.
Metz CN; Thomas P; Davitz MA
Am J Pathol; 1992 Jun; 140(6):1275-81. PubMed ID: 1376554
[TBL] [Abstract][Full Text] [Related]
10. Glycosylphosphatidylinositol-specific phospholipase D of human serum--activity modulation by naturally occurring amphiphiles.
Rhode H; Schulze M; Cumme GA; Göhlert A; Blume E; Bublitz R; Schilling K; Horn A
Biol Chem; 2000; 381(5-6):471-85. PubMed ID: 10937880
[TBL] [Abstract][Full Text] [Related]
11. Screening and modulation of extracellular signals by mucous barrier. Serum glycosylphosphatidylinositol phospholipase D (GPI-PLD) releases protective mucous barrier from oral mucosa.
Slomiany A; Nishikawa H; Slomiany BL
J Physiol Pharmacol; 2002 Mar; 53(1):21-38. PubMed ID: 11939716
[TBL] [Abstract][Full Text] [Related]
12. Solubilization of liver alkaline phosphatase isoenzyme during cholestasis in dogs.
Solter PF; Hoffmann WE
Am J Vet Res; 1999 Aug; 60(8):1010-5. PubMed ID: 10451214
[TBL] [Abstract][Full Text] [Related]
13. In vitro phosphorylation of purified glycosylphosphatidylinositol-specific phospholipase D.
Civenni G; Bütikofer P; Stadelmann B; Brodbeck U
Biol Chem; 1999 May; 380(5):585-8. PubMed ID: 10384965
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting the ability of glycosylphosphatidylinositol-specific phospholipase D to degrade the membrane anchors of cell surface proteins.
Low MG; Huang KS
Biochem J; 1991 Oct; 279 ( Pt 2)(Pt 2):483-93. PubMed ID: 1835378
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of glycosylphosphatidylinositol (GPI) phospholipase D by suramin-like compounds.
Brunner G; Zalkow L; Burgess E; Rifkin DB; Wilson EL; Gruszecka-Kowalik E; Powis G
Anticancer Res; 1996; 16(5A):2513-6. PubMed ID: 8917344
[TBL] [Abstract][Full Text] [Related]
16. Glycosylphosphatidylinositol-specific phospholipase D influences triglyceride-rich lipoprotein metabolism.
Raikwar NS; Cho WK; Bowen RF; Deeg MA
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E463-70. PubMed ID: 16219662
[TBL] [Abstract][Full Text] [Related]
17. A distant evolutionary relationship between GPI-specific phospholipase D and bacterial phosphatidylcholine-preferring phospholipase C.
Rigden DJ
FEBS Lett; 2004 Jul; 569(1-3):229-34. PubMed ID: 15225639
[TBL] [Abstract][Full Text] [Related]
18. Expression of intracellular and GPI-anchored forms of GPI-specific phospholipase D in COS-1 cells.
Küng M; Bütikofer P; Brodbeck U; Stadelmann B
Biochim Biophys Acta; 1997 Jul; 1357(3):329-38. PubMed ID: 9268057
[TBL] [Abstract][Full Text] [Related]
19. Glycosylphosphatidylinositol-specific phospholipase D in blood serum: is the liver the only source of the enzyme?
Rhode H; Lopatta E; Schulze M; Pascual C; Schulze HP; Schubert K; Schubert H; Reinhart K; Horn A
Clin Chim Acta; 1999 Mar; 281(1-2):127-45. PubMed ID: 10217634
[TBL] [Abstract][Full Text] [Related]
20. GPI-specific phospholipase D (GPI-PLD) is expressed during mouse development and is localized to the extracellular matrix of the developing mouse skeleton.
Gregory P; Kraemer E; Zürcher G; Gentinetta R; Rohrbach V; Brodbeck U; Andres AC; Ziemiecki A; Bütikofer P
Bone; 2005 Aug; 37(2):139-47. PubMed ID: 15946906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
